Semi-Annual Securities Report — FY2026 H1
What BML,INC. reported for the period from 2026-04-01 to 2027-03-31.
Filed 2026-11-13View the original on EDINET
How much it says
64Detailed
What moved here
14named for the first time
Its own wording
21terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim consolidated accounting period, net sales were ¥78,038 million, up 3.2% year on year. Operating profit and ordinary profit increased, while interim net income attributable to owners of the parent decreased, down 4.9% year on year. In addition, from 27 April 2026, the Company began providing genetic analysis services for cardiomyopathies, using NGS-based panel analysis, in collaboration with the Center for Genetic Medicine Research at Shinshu University Hospital. Research and development expenses were ¥147 million.
Komori's summary of this document, not the document's own words.64Detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 36 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
68
Detailed
82
Very detailed
75
Very detailed
0
Almost nothing
68
Detailed
50
Typical
100
Very detailed
53
Typical
55
Typical
73
Detailed
R&D spend1億円Money spent making new things.
Cash left over-33億円Cash from the business, less what went into equipment.
Spent on equipment82億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.